Unknown

Dataset Information

Fragment-based discovery of 6-azaindazoles as inhibitors of bacterial DNA ligase.


ABSTRACT: Herein we describe the application of fragment-based drug design to bacterial DNA ligase. X-ray crystallography was used to guide structure-based optimization of a fragment-screening hit to give novel, nanomolar, AMP-competitive inhibitors. The lead compound 13 showed antibacterial activity across a range of pathogens. Data to demonstrate mode of action was provided using a strain of S. aureus, engineered to overexpress DNA ligase.

SUBMITTER: Howard S 

PROVIDER: S-EPMC4027552 | biostudies-literature | 2013 Dec

REPOSITORIES: biostudies-literature